Frontiers in ImmunologyImmunologyPeer-reviewed journal article
Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.
Remy Thomas, Ahmed ZaqoutiD, Bakhita Meqbel, Umar Jafar, Nishant N. VaikathiD, Abdullah AldushainiD, Adviti NaikiD, Hibah ShaathiD, Neyla S. Al-Akl, Abdi Adam, Houda Yasmine Ali MoussaiD, Kyung Chul ShiniD, Rowaida Ziad TahaiD, Mohammed AbukhattabiD, Muna A. Rahman S. AlMaslamaniiD, Nehad M. AlajeziD, Abdelilah ArredouaniiD, Yongsoo ParkiD, Sara A. AbdullaiD, Omar M. A. El‐AgnafiD, Ali Senosi OmraniiD, Julie V. DecockiD
Abstract
IntroductionIn March 2020, the rapid spread of SARS-CoV-2 prompted global vaccination campaigns to mitigate COVID-19 disease severity and mortality. The 2-dose BNT162b2- mRNA vaccine effectively reduced infection and mortality rates, however, waning vaccine effectiveness necessitated the introduction of a third vaccine dose or booster. To assess the magnitude and longevity of booster-induced immunity, we conducted a longitudinal study of SARS-CoV-2 specific cellular and humoral immune responses among Qatars vulnerable craft and manual worker community. We also investigated the impact of prior naturally acquired immunity on booster vaccination efficacy. MethodsSeventy healthy participants were enrolled in the study, of whom half had prior SARS-CoV-2 infection. Blood samples were collected before and after booster vaccination to evaluate immune responses through SARS- CoV-2 specific ELISpots, IgG ELISA, neutralization assays, and flow cytometric immunophenotyping ResultsT cell analysis revealed increased Th1 cellular responses, marked by enhanced IFN-{gamma} release, in recently infected participants, which was further enhanced by booster vaccination for up to 6-months. Furthermore, booster vaccination stimulated cytotoxic T cell responses in infection-naive participants, characterized by granzyme B production. Both natural SARS-CoV-2 infection and booster vaccination induced robust and durable SARS-CoV-2 specific humoral immune responses, with high neutralizing antibody levels. Prior natural infection was also linked to an increased number of class- switched B cells prior to booster vaccination. ConclusionThese findings underscore the importance of booster vaccination in enhancing anti-viral immunity across both infection-naive and previously infected individuals, enhancing distinct arms of the anti-viral immune response and prolonging naturally acquired immunity.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 5
- FWCI
- 3.82
- Field percentile
- top 7%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
C. Camara, D. Lozano-Ojalvo, … J. Ochando·bioRxiv·Mar 22, 2021
- The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity.
G. Borsellino, G. Guerrera, … L. Battistini·Science ImmunologyPeer-reviewed·Dec 24, 2021
- Durability of immune responses to the BNT162b2 mRNA vaccine
M. Suthar, P. S Arunachalam, … P. Halfmann·bioRxiv·Sep 30, 2021
- Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
M. Nayrac, M. Dube, … D. E. Kaufmann·bioRxiv·Dec 18, 2021
- Long-term Humoral Immune Dynamics After SARS-CoV-2 Vaccination and Infection in Healthcare Workers: The VaCoMRI Study
Mehmet Tekinsoy, Osman Merdan, … Ulrike Protzer·bioRxiv·Jun 12, 2026
- Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naive and pre-immune humans
D. Forgacs, H. Jang, … T. M. Ross·bioRxiv·May 29, 2021